BEGIN:VCALENDAR
PRODID:NingEventWidget-v1
VERSION:2.0
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:2140535:Event:80510
DTSTAMP:20260523T170746Z
SUMMARY:R2 Addendum- Changes Impacting Sponsors-CRO-Sites
DESCRIPTION:Overview:The revised guidelines are entitled \"Integrated 
 Addendum To ICH E6(R1): Guideline For Good Clinical Practice E6(R2).\"
  The ICH steering committee comprised of representatives from the phar
 maceutical industry and the regulatory bodies of the United States, Ja
 pan, the European Union (EU), Canada, and Switzerland.\nWhy should you
  Attend:In this webinar we will identify the changes impacting investi
 gators, sites, Sponsors, CROs: responsibilities and roles and explain 
 the impact of the revisions on clinical trials conduct and organizatio
 nal practices.\nAreas Covered in the Session:GCP E6 R2 GuidelineGlobal
 izationRisk-based Quality Management (RBQM)SOPs development and implem
 entation, Standardization\nWho Will Benefit:Directors of Clinical Oper
 ationsMedical Affairs Specialists and Leaders of this DivisionProject 
 ManagersGrant AdministratorsRegulatory AffairsQuality Control(QC), Qua
 lity Assurance Specialists\nSpeaker Profile:Dr. Malikova has over four
 teen years of experience in the clinical research field. She has manag
 ed Phase I – IV studies involving investigational drugs, devices and
  biologics. She has worked on Industry-sponsored and Investigator-init
 iated trials in the fields of Surgery, Cancer Diagnostics and Interven
 tional Radiology.\nEvent Fee: One Dial-in One Attendee Price: US $150.
 00\nContact Detail:Compliance4All DBA NetZealous,Phone: +1-800-447-940
 7Email: support@compliance4All.com\n\nFor more information visit https
 ://medtechiq.ning.com/events/r2-addendum-changes-impacting-sponsors-cr
 o-sites
DTSTART;TZID=America/New_York:20181106T100000
DTEND;TZID=America/New_York:20181106T110000
CATEGORIES:webinar
LOCATION:161 Mission Falls Lane, Suite 216,
WEBSITE:https://www.compliance4all.com/control/w_product/~product_id=5
 02188LIVE?channel=medtechiq_Nov_2018_SEO
URL:https://www.compliance4all.com/control/w_product/~product_id=50218
 8LIVE?channel=medtechiq_Nov_2018_SEO
CONTACT:8004479407
ORGANIZER;CN="Adam Fleming":https://medtechiq.ning.com/profile/Complia
 nce4all
ATTACH;FMTTYPE="image/jpeg":http://storage.ning.com/topology/rest/1.0/
 file/get/2562019873?profile=original
ATTENDEE;ROLE=REQ-PARTICIPANT;PARTSTAT=ACCEPTED;RSVP=TRUE;CN="Adam Fle
 ming":https://medtechiq.ning.com/profile/Compliance4all
END:VEVENT
END:VCALENDAR